drugset / Trial / NCT01560143
Pharmacokinetics Of Tigecycline In Morbidly Obese Subjects
NaSingle-groupOpen-label
Summary
If tigecycline clearance increases with body size then serum exposure values will be lower in obese class III compared to normal weight subjects because exposure changes inversely with clearance when the dose is fixed without regard to weight.
Timeline
- Start
- 2012-03
- Primary completion
- 2012-05
- Completion
- 2012-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tigecycline | Small molecule | 100 mg | Intravenous |